Moody’s assigns ‘Aa3’ rating to Memorial Sloan-Kettering Cancer Center’s bonds

Moody’s Investors Service has assigned an “Aa3” rating to up to $550 million of New York City-based Memorial Sloan-Kettering Cancer Center’s taxable, fixed rate series 2015 revenue bonds.

Advertisement

The rating assignment was supported by a number of factors, including MSKCC’s excellent market position and improved operating performance. The center ended the first nine months of fiscal 2014 with a 2.5 percent operating margin and a 12.3 operating cash flow margin.

MSKCC also faces some challenges, which were considered for the rating assignment, such as being involved in a period of capital investment.

The center’s outlook is stable, and according to Moody’s the outlook reflects the expectation “that the capital projects will open on-time and on-budget and that debt service coverage will improve as new revenue-generating facilities open.”

More articles on healthcare finance:

8 recent hospital, health system capital projects
8 recent hospital rating and outlook changes, affirmations
5 hospital CFOs in the headlines this week

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-MetrixPaul Summers, Nevada Heart & Vascular

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.